Page last updated: 2024-11-12

3-acrylamidophenylboronic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10321331
SCHEMBL ID235432
MeSH IDM0378474

Synonyms (33)

Synonym
99349-68-5
3-acrylamidophenylboronic acid
(3-acrylamidophenyl)boronic acid
A846009
(m-acrylamidophenyl)boronic acid
AKOS006291555
3-(acrylamido)phenylboronic acid
FT-0685348
SCHEMBL235432
[3-(prop-2-enoylamino)phenyl]boronic acid
AM808126
boronic acid, b-[3-[(1-oxo-2-propen-1-yl)amino]phenyl]-
3-acrylamido-phenylboronic acid
ULVXDHIJOKEBMW-UHFFFAOYSA-N
(3-acrylamidophenyl)-boronic acid
J-502078
AC-30997
DTXSID50438076
3-(acrylamido)phenylboronic acid, 98%
(m-acrylamido)phenylboronic acid
mfcd09025755
CS-W001006
GS-5726
[3-(prop-2-enamido)phenyl]boronic acid
3-(acryloylamino)benzeneboronic acid
SY066256
3-acrylamidophenylboronic acid (contains varying amounts of anhydride)
3-acrylamidobenzeneboronic acid
(m-acrylamidophenyl)boronicacid
149698-08-8
phenylboronate acrylamide
CS-0067138
(3-acrylamidophenyl)boronicacid

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Mucoadhesive drug delivery systems have the potential to improve topical drug delivery by increasing pharmaceutical bioavailability on the anterior eye surface."( Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
Kedzior, S; Muirhead, B; Prosperi-Porta, G; Sheardown, H, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" This novel preparation can enable new combinations of plant extracts and biomaterials to adiministered through NPs or other dosage forms in order to regulate and treat diseases."( Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.
Bian, L; Ma, Q; Shi, A; Wu, J; Yan, X; Zhang, P; Zhao, X, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (17.24)29.6817
2010's21 (72.41)24.3611
2020's3 (10.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.24 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]